Intended for healthcare professionals

Rapid response to:

News

Sixty seconds on . . . antidepressants

BMJ 2017; 356 doi: https://doi.org/10.1136/bmj.j249 (Published 16 January 2017) Cite this as: BMJ 2017;356:j249

Rapid Response:

Re: Sixty seconds on . . . antidepressants... forgetting side effects and deaths.

A grown up debate about the management of depressive symptoms was needed when my grandfather prescribed bromides to neurasthenic casualties from the first World War. My father was persuaded by pharma to prescribe the “safe” barbiturates in the 1930s, moving to the even “safer” benzodiazepines and tricyclics, thirty years later.
The baton of pharma profits was passed to the SSRIs in my time.
Hawkes’ sixty second whizz around the current antidepressant scene manages not a second on the harms, and deaths, that antidepressants cause. (1)
This snippet may mark another step on the descent of the BMJ to medical comic status.
Does it satisfy sound commercial criteria, perhaps ?
We were recently informed that the BMJ receives “..about £7.5M every year “ from pharmaceutical companies. (2)

1 Peter C Gøtzsche , Deadly Psychiatry and Organised Denial, Peoples Press, 2015.
2 http://www.bmj.com/content/351/bmj.h3908/rr-12

Competing interests: No competing interests

23 January 2017
Noel Thomas
retd/part time GP
BronyGarn, Maesteg, Wales CF34 9AL